Filtered By:
Condition: Atrial Fibrillation
Infectious Disease: COVID-19

This page shows you your search results in order of relevance. This is page number 6.

Order by Relevance | Date

Total 196 results found since Jan 2013.

Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in Poland
CONCLUSION: Among cardiovascular risk factors and diseases, HF and DM appeared to increase in-hospital COVID-19 mortality, whereas the use of cardiovascular drugs was associated with lower mortality.PMID:33926173 | DOI:10.33963/KP.15990
Source: Kardiologia Polska - April 30, 2021 Category: Cardiology Authors: Micha ł Terlecki Wiktoria Wojciechowska Marek Klocek Agnieszka Olszanecka Katarzyna Stolarz-Skrzypek Tomasz Grodzicki Maciej Ma łecki Barbara Katra Aleksander Garlicki Monika Boci ąga-Jasik Krzysztof S ładek Andrzej Matyja Jerzy Wordliczek Agnieszka S Source Type: research

Imaging test may predict patients most at risk of some heart complications from COVID-19
(Johns Hopkins Medicine) Researchers at Johns Hopkins Medicine have shown that a type of echocardiogram, a common test to evaluate whether a person's heart is pumping properly, may be useful in predicting which patients with COVID-19 are most at risk of developing atrial fibrillation -- an irregular heartbeat that can increase a person's risk for heart failure and stroke, among other heart issues.
Source: EurekAlert! - Medicine and Health - July 8, 2021 Category: International Medicine & Public Health Source Type: news

Maximising Opportunities Post Coronavirus Disease 2019: Time to Embrace a New Era of Atrial Fibrillation Research
In this edition of Arrhythmia& Electrophysiology Review there is a strong emphasis on different aspects of AF care, including the use of remote monitoring accelerated by the coronavirus disease 2019 (COVID-19) pandemic, stroke risk and optimisation of therapy with ablation. Indeed, an elegant mechanistic paper highlights the...
Source: Radcliffe Cardiology - July 12, 2021 Category: Cardiology Authors: c242508f1d9059bc0f2aa9bdd5421ba2 Source Type: research

Pulmonary Embolism and Cardiac Tamponade in Critical Care Patients with COVID-19; Telemedicine's Role in Developing Countries: Case Reports and Literature Review
CONCLUSIONS: During admission, both patients had sudden deterioration characterized by oxygen desaturation and hypotension necessitating inotropic support. As a result, for both patients, bedside echocardiography was performed by the attending intensivist. Echocardiographic findings showed cardiac tamponade and acute pulmonary embolism, respectively, which were confirmed by a cardiologist through telemedicine technology. Proper emergency management was initiated, and both patients recovered well. Limited bedside transthoracic echocardiography had a front-line impact on the treatment and outcome of the two patients with COV...
Source: Pain Physician - August 2, 2021 Category: Anesthesiology Authors: Islam Mohammed Sheata Scott Richard Smith Heba Kamel Giustino Varrassi Farnad Imani Abdolreza Dayani Dariusz Myrcik Ivan Urits Omar Viswanath Sameh Salem Taha Source Type: research

Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study
ConclusionAmong hospitalized patients with COVID-19, a history of AF contributes to worse clinical course with a higher mortality and in-hospital events including new-onset AF, acute HF, and multiorgan failure. The mortality risk remains significant after adjustment for variables associated with COVID-19 severity and comorbidities.
Source: Europace - July 23, 2021 Category: Cardiology Source Type: research

Colchicine-new horizons for an ancient drug
Eur J Intern Med. 2021 Oct 14:S0953-6205(21)00332-0. doi: 10.1016/j.ejim.2021.10.002. Online ahead of print.ABSTRACTColchicine is an old, inexpensive, and relatively safe anti-inflammatory drug traditionally used in gout and over the last 50 years in familial Mediterranean fever. A search of all high-hierarchy studies (randomized controlled trials [RCTs], systematic reviews and meta-analysis of RCTs) over the last 20 years revealed myriad other evidence-based applications. Colchicine seems efficacious in the treatment of acute pericarditis and prevention of recurrences and the prevention of postcardiac injury syndrome and ...
Source: European Journal of Internal Medicine - October 18, 2021 Category: Internal Medicine Authors: Ami Schattner Source Type: research

New-Onset Atrial Fibrillation in Patients With Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease  - Insights From the CLAVIS-COVID Registry
CONCLUSIONS: Patients with NOAF had significantly worse outcomes as compared to patients with pre-existing AF and SR. The incidence of NOAF would be a useful predictor of clinical outcomes during hospitalization.PMID:35082216 | DOI:10.1253/circj.CJ-21-0911
Source: Circulation Journal - January 27, 2022 Category: Cardiology Authors: Takahide Sano Shingo Matsumoto Takanori Ikeda Shunsuke Kuroda Takeshi Kitai Taishi Yonetsu Shun Kohsaka Sho Torii Koichi Node Yuya Matsue Source Type: research